Neutrophil Extracellular Traps in Stroke (NET-STROKE)

Neutrophil Extracellular Traps in Stroke (NET-STROKE) - NET-STROKE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030601

Enrollment

200

Registered

2023-01-02

Start date

2023-01-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I61 I63

Interventions

Group 1: Visits at day 1, 2, 6 and 90. For details see study protocol.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1. Age >= years) 2. Clinical signs of ischemic or hemorrhagic (atraumatic) stroke with imaging correlates (CCT, MRI) 3. Time from symptom onset to admission at UKA =1 5. Signed consent form

Exclusion criteria

Exclusion criteria: 1. Acute disease within the last 4 weeks (intracranial hemorrhage, stroke, myocardial infarction, occlusion of peripheral arteries, venous thrombosis) 2. Active malignant disease 3. Active immune-mediate disease and / or immunosuppressive therapy 4. Palliative care established or planed

Design outcomes

Primary

Measure	Time frame
Not applicable (explorative) Descriptive: Functional Outcome at 3 months according to modified Rankin Scale (mRS) at 3 month	—

Countries

Germany

Contacts

Public ContactHauke Schneider

Klinik für Neurologie, Universitätsklinikum Augsburg

hauke.schneider@uk-augsburg.de0821-4002854

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026